EMEA-002474-PIP02-18

Key facts

Active substance
levonorgestrel
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/0302/2019
PIP number
EMEA-002474-PIP02-18
Pharmaceutical form(s)
Vaginal delivery system
Condition(s) / indication(s)
Prevention of pregnancy
Route(s) of administration
Vaginal use
Contact for public enquiries
Chemo Research, S.L.

Tel. +34 913021560
E-mail: monica.diez@exeltis.com

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating